Cargando…

Association of Transferrin Gene Polymorphism with Cognitive Deficits and Psychiatric Symptoms in Patients with Chronic Schizophrenia

A large amount of recent literature has focused on impaired iron homeostasis in the pathophysiology of schizophrenia. Specifically, microarray analysis has illustrated associations between the transferrin locus and schizophrenia. To elaborate on the effects of transferrin on schizophrenia and its ps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Pinhong, Wang, Dongmei, Xiu, Meihong, Chen, Dachun, Lackey, Blake, Wu, Hanjing E., Wang, Lubin, Zhang, Xiangyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654946/ https://www.ncbi.nlm.nih.gov/pubmed/36362642 http://dx.doi.org/10.3390/jcm11216414

Ejemplares similares

Polymorphism of Transferrin Gene Impacts the Mediating Effects of Psychotic Symptoms on the Relationship between Oxidative Stress and Cognition in Patients with Chronic Schizophrenia
por: Chen, Pinhong, et al.
Publicado: (2022)

Suicide attempts in Chinese Han patients with schizophrenia: cognitive, demographic, and clinical variables
por: Dai, Qilong, et al.
Publicado: (2020)

Association between Thalamocortical Functional Connectivity Abnormalities and Cognitive Deficits in Schizophrenia
por: Chen, Pinhong, et al.
Publicado: (2019)

The inconsistent mediating effect of catechol O methyl transferase Val(158)Met polymorphism on the sex difference of cognitive impairment in schizophrenia patients
por: Xu, Hang, et al.
Publicado: (2022)

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia
por: Lang, Xiao-E, et al.
Publicado: (2018)

Sexual dimorphism in the relationship between Forkhead-Box P2 and BMI with cognitive deficits in schizophrenia
por: Yang, Mi, et al.
Publicado: (2022)

Eye movement characteristics in male patients with deficit and non-deficit schizophrenia and their relationships with psychiatric symptoms and cognitive function
por: Zhang, Lin, et al.
Publicado: (2021)

Association between TNF-alpha polymorphism and the age of first suicide attempt in chronic patients with schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2020)

Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
por: Lin, Chen, et al.
Publicado: (2021)

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
por: Su, Xiuru, et al.
Publicado: (2021)

Diabetes and Cognitive Deficits in Chronic Schizophrenia: A Case-Control Study
por: Han, Mei, et al.
Publicado: (2013)

Repetitive transcranial magnetic stimulation for psychiatric symptoms in long-term hospitalized veterans with schizophrenia: A randomized double-blind controlled trial
por: Su, Xiuru, et al.
Publicado: (2022)

Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
por: Xiu, Meihong, et al.
Publicado: (2023)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
por: Wang, Keqiang, et al.
Publicado: (2022)

Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia
por: Li, Jiaxin, et al.
Publicado: (2023)

Interactive effect of MTHFR C677T polymorphism and sex on symptoms and cognitive functions in Chinese patients with chronic schizophrenia
por: Gao, Jie, et al.
Publicado: (2020)

The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study
por: Liu, Jiahong, et al.
Publicado: (2021)

Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables
por: Yu, Miao, et al.
Publicado: (2015)

Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia
por: Wei, Chang Wei, et al.
Publicado: (2020)

Metacognitive Beliefs, Cognitive Functioning, Psychiatric Symptoms and Empathy in People with Schizophrenia
por: Chuang, Shu Ping, et al.
Publicado: (2021)

Transferrin In Korean Children With Attention Deficit Hyperactivity Disorder
por: Kwon, Ho Jang, et al.
Publicado: (2011)

Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder
por: Jeon, Soo Min, et al.
Publicado: (2023)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Association of Alexithymia With Positive Symptoms in Chinese Chronic Schizophrenia Patients With and Without Obesity
por: Tian, Yang, et al.
Publicado: (2023)

Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
por: Wu, Zhiwei, et al.
Publicado: (2021)

A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophrenia
por: Wang, Pingping, et al.
Publicado: (2023)

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
por: Chen, Xiaofang, et al.
Publicado: (2023)

Exploring the link between cognitive deficit, self‐esteem, alexithymia, and depressive symptom of schizophrenia
por: He, Chen, et al.
Publicado: (2022)

Electroconvulsive Therapy Reduces Protein Expression Level of EP300 and Improves Psychiatric Symptoms and Disturbance of Thought in Patients with Schizophrenia
por: Peng, Wanhong, et al.
Publicado: (2023)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area
por: Wang, Yan, et al.
Publicado: (2020)

Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia
por: Yang, Mi, et al.
Publicado: (2020)

Association between Empathy and Clinical Symptoms among Overweight and Non-Overweight Chinese Chronic Schizophrenia Patients
por: Li, Yuchen, et al.
Publicado: (2023)

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2023)

T47. IS THERE A DIURNAL VARIATION IN PSYCHIATRIC SYMPTOMS IN SCHIZOPHRENIA?
por: Daniel, David, et al.
Publicado: (2018)

Cognitive deficits, depressive symptoms, insight, and medication adherence in remitted patients with schizophrenia
por: Settem, V. V. Jagadeesh, et al.
Publicado: (2019)

Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment
por: Ye, Jiaen, et al.
Publicado: (2019)

Cognitive deficits in familial schizophrenia
por: Saha, Aneek, et al.
Publicado: (2021)

Correlation of neurocognitive deficits with positive and negative symptoms in schizophrenia
por: Priyamvada, Richa, et al.
Publicado: (2021)

Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism
por: Su, Xiuru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jkjae50q35k88qh1lsk9uefa4l